Sandoz And Samsung Celebrate Stelara Rival’s EU Approval

Pyzchiva Biosimilar Version Of Ustekinumab Receives European Commission Nod

 
• By David Wallace
  
Red wooden figure waiting second in line with other wooden figures
Sandoz and Samsung's Pyzchiva is the second of many ustekinumab biosimilar filings to receive approval in the EU • Source: Shutterstock

More from Biosimilars

More from Products